A cross-sectional study of attitudes and behaviors of snuff use and cessation among people with and without HIV in South Africa.

HIV smokeless tobacco snuff tobacco

Journal

Tobacco use insights
ISSN: 1179-173X
Titre abrégé: Tob Use Insights
Pays: United States
ID NLM: 101608659

Informations de publication

Date de publication:
2023
Historique:
received: 13 04 2023
accepted: 25 07 2023
pubmed: 14 8 2023
medline: 14 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

Despite a high (48%) prevalence of snuff use among women with HIV in South Africa, little is known of the attitudes and behaviors of use, strategies for cessation, and potential health risks. In a cross-sectional study, a questionnaire was administered to adults (≥18 years) with (HIV+) and without HIV (HIV-) who self-reported current snuff use to collect information on demographics, snuff use and cessation attempts, preferred strategies for cessation, other substance use, history of respiratory illness, and mental health. 150 (74 HIV+, 76 HIV-) participants were enrolled; 115 (77%) were daily snuff users, 6 (4%) were current smokers, and 17 (11%) former smokers. Top reasons for current snuff use included improving health (n = 48, 32%), reducing stress (n = 26, 16%), and "being a habit" (n = 38, 25%). Participants believed snuff use to have mostly positive (n = 68, 46%) or no (n = 54, 36%) health impacts, and 57 (38%) participants believed snuff cures headaches. 103 (69%) participants reported a previous quit attempt, and 110 (73%) indicated high interest in quitting snuff. Although 105 (70%) participants indicated that advice from a healthcare provider would aid them in quitting snuff, only 30 (20%) reported ever receiving that advice. A majority of participants (n = 141, 94%) suffer from moderate to high levels of perceived stress, and overall few differences were seen by HIV status. Education on negative impacts of snuff, advice to quit from healthcare providers, and nicotine replacement therapy should be considered in the development of a snuff cessation program.

Sections du résumé

Background UNASSIGNED
Despite a high (48%) prevalence of snuff use among women with HIV in South Africa, little is known of the attitudes and behaviors of use, strategies for cessation, and potential health risks.
Methods UNASSIGNED
In a cross-sectional study, a questionnaire was administered to adults (≥18 years) with (HIV+) and without HIV (HIV-) who self-reported current snuff use to collect information on demographics, snuff use and cessation attempts, preferred strategies for cessation, other substance use, history of respiratory illness, and mental health.
Results UNASSIGNED
150 (74 HIV+, 76 HIV-) participants were enrolled; 115 (77%) were daily snuff users, 6 (4%) were current smokers, and 17 (11%) former smokers. Top reasons for current snuff use included improving health (n = 48, 32%), reducing stress (n = 26, 16%), and "being a habit" (n = 38, 25%). Participants believed snuff use to have mostly positive (n = 68, 46%) or no (n = 54, 36%) health impacts, and 57 (38%) participants believed snuff cures headaches. 103 (69%) participants reported a previous quit attempt, and 110 (73%) indicated high interest in quitting snuff. Although 105 (70%) participants indicated that advice from a healthcare provider would aid them in quitting snuff, only 30 (20%) reported ever receiving that advice. A majority of participants (n = 141, 94%) suffer from moderate to high levels of perceived stress, and overall few differences were seen by HIV status.
Conclusions UNASSIGNED
Education on negative impacts of snuff, advice to quit from healthcare providers, and nicotine replacement therapy should be considered in the development of a snuff cessation program.

Identifiants

pubmed: 37577008
doi: 10.1177/1179173X231193890
pii: 10.1177_1179173X231193890
pmc: PMC10422901
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1179173X231193890

Informations de copyright

© The Author(s) 2023.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Samantha M Loh (SM)

Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.

Tumelo Moloantoa (T)

Perinatal HIV Research Unit, Soweto, South Africa.

Nompumelelo Yende (N)

Perinatal HIV Research Unit, Soweto, South Africa.

Ebrahim Variava (E)

Department of Internal Medicine, Klerksdorp Tshepong Hospital Complex, Matlosana, South Africa.

Raymond Niaura (R)

Department of Epidemiology; Department of Social and Behavioral Sciences, New York University, New York, NY, USA.

Jonathan E Golub (JE)

Department of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Neil Martinson (N)

Perinatal HIV Research Unit, Soweto, South Africa.

Jessica L Elf (JL)

Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.

Classifications MeSH